NCT02603406View on ClinicalTrials.gov

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 15, 2016

Primary Completion Date

July 16, 2019

Study Completion Date

December 31, 2019

Conditions
AngiogenesisIschemic Stroke
Interventions
DRUG

erythropoietin

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Ajou University School of Medicine

OTHER